- Home
- CRVO vs CLIR Comparison
CRVO vs CLIR Comparison
Compare CRVO & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRVO | CLIR |
|---|---|---|
| Founded | 2001 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9M | 26.6M |
| IPO Year | 2011 | 2011 |
Fundamental Metrics
Financial Performance| Metric | CRVO | CLIR |
|---|---|---|
| Price | $2.62 | $4.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $23.00 | $20.00 |
| AVG Volume (30 Days) | ★ 327.3K | 9.2K |
| Earning Date | 05-12-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,006,510.00 | $530,000.00 |
| Revenue This Year | N/A | $34.29 |
| Revenue Next Year | N/A | $67.31 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.13 | $0.39 |
| 52 Week High | $10.89 | $7.56 |
Technical Indicators
Market Signals| Indicator | CRVO | CLIR |
|---|---|---|
| Relative Strength Index (RSI) | 41.42 | 70.95 |
| Support Level | $2.43 | $3.70 |
| Resistance Level | $4.27 | $4.75 |
| Average True Range (ATR) | 0.20 | 0.26 |
| MACD | 0.02 | 0.10 |
| Stochastic Oscillator | 25.97 | 78.36 |
Price Performance
Historical ComparisonAbout CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in designing and develop technologies for the purpose of decarbonization and improving key performance characteristics of industrial and commercial combustion systems, including emission and operational performance, energy efficiency and overall cost-effectiveness. Its ClearSign Core technology has been proved to be in full scale industrial test furnaces and boilers and first customer installations are currently operating in normal commercial applications The company offers products that include process burners, boiler burners, flares, and ClearSign Eye. The company operates in one segment: Combustion segment. The products of the company include: Process Burners, Midstream and Power, Flares, Boiler Burners, and Sensing Technology.